Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 126 Breast Neoplasms 78 Neoplasms 48 Prostatic Neoplasms 19 Fatigue 16 Obesity 14 Colorectal Neoplasms 13 Lung Neoplasms 11 Polycystic Ovary Syndrome 10 Colonic Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Head and Neck Neoplasms 7 Weight Loss 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Multiple Myeloma 5 Lymphedema 5 Leukemia 5 Inflammation 5 Pancreatic Neoplasms 4 Overweight 4 Multiple Endocrine Neoplasia Type 1 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Insulin Resistance 4 Depression 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Stomach Neoplasms 3 Peripheral Nervous System Diseases 3

Interventions

sotrovimab 1 ciclesonide 1 Niclosamide 1 High-Intensity Interval Training 1 Exercise 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lupus Erythematosus, Systemic × Exercise × Clear all

NCT05478018 2025-09-09

LUPEX

Rigshospitalet, Denmark

Phase NA Completed

Lupus Erythematosus, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡